^
BIOMARKER:

KEAP1 mutation

i
Other names: KEAP1, Kelch Like ECH Associated Protein 1, Cytosolic Inhibitor Of Nrf2, Kelch-Like Family Member 19, Kelch-Like Protein 19, KLHL19, INrf2, KEAP1 Delta C, KIAA0132, INRF2
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
Related biomarkers:
KEAP1 mutation
Non Small Cell Lung Cancer
durvalumab + CP-675206
Sensitive
:
B
ESMO 2022 - 3 weeks - (New B)
KEAP1 mutation
Non Small Cell Lung Cancer
pembrolizumab + ramucirumab
Sensitive
:
C3
ESMO 2022 - 3 weeks - (New C3)
KEAP1 mutation
Non Small Cell Lung Cancer
DRP-104
Sensitive
:
B
KEAP1 mutation
Non Small Cell Lung Cancer
durvalumab
Resistant
:
B
KEAP1 mutation
Solid Tumor
IPN60090
Sensitive
:
C2
KEAP1 mutation
Lung Non-Small Cell Squamous Cancer
CB-228
Sensitive
:
C2
KEAP1 mutation
Non Small Cell Lung Cancer
rivoceranib + camrelizumab
Sensitive
:
C3
KEAP1 mutation
Lung Non-Squamous Non-Small Cell Cancer
docetaxel
Resistant
:
C3
KEAP1 mutation
Lung Non-Squamous Non-Small Cell Cancer
atezolizumab
Resistant
:
C3
KEAP1 mutation
Lung Non-Squamous Non-Small Cell Cancer
rivoceranib + camrelizumab
Sensitive
:
C3
KEAP1 mutation
Non Small Cell Lung Cancer
atezolizumab
Resistant
:
C3
KEAP1 mutation
Non Small Cell Lung Cancer
PD-L1 inhibitor
Sensitive
:
C3
KEAP1 mutation
Non Small Cell Lung Cancer
Immunotherapy
Resistant
:
C3
KEAP1 mutation
Lung Adenocarcinoma
Immunotherapy
Resistant
:
C3
KEAP1 mutation
Lung Adenocarcinoma
CB-228 + CB-839
Sensitive
:
C3
KEAP1 mutation
Lung Adenocarcinoma
DRP-104
Sensitive
:
D
KEAP1 mutation
Lung Cancer
IPN60090
Sensitive
:
D